• / Free eNewsletters & Magazine
  • / My Account
Home>Drug Companies

Drug Companies

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Research and Markets: OTC Pharmaceuticals : Global Industry Guide 2014-2018: Market to value $170,812.0m by the end of 2018

    Research and Markets: OTC Pharmaceuticals : Global Industry Guide 2014-2018: Market to value $170,812.0m by the end of 2018

  2. Research and Markets: OTC Pharmaceuticals : Global Industry Almanac 2014

    Research and Markets: OTC Pharmaceuticals : Global Industry Almanac 2014

  3. Actavis to Acquire Auden Mckenzie for 306M GBP

    Actavis to Acquire Auden Mckenzie for 306M GBP

  4. Regeneron and Sanofi Announce Praluent™ (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

    Regeneron and Sanofi Announce Praluentâ„¢ (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

  5. Teva's generic version of AstraZeneca's Nexium gets FDA approval

    Teva's generic version of AstraZeneca's Nexium gets FDA approval

  6. Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC

    Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC

  7. Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC

    Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC

  8. Fresenius Medical Care Activates Disaster Response Team and Patient Hotline for Winter Storm Juno in the Northeast

    Fresenius Medical Care Activates Disaster Response Team and Patient Hotline for Winter Storm Juno in the Northeast

  9. Singapore December Industrial Output Falls Less Than Expected

    Singapore December Industrial Output Falls Less Than Expected

  10. Roche receives FDA clearance for next generation cobas MRSA/SA Test

    Roche receives FDA clearance for next generation cobas MRSA/SA Test

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.